This would likely include breast cancer, hepatocellular carcinoma, and prostate cancer, to name a few, and possibly MPNST, if future investigations verify our prediction based on mounting evidence that FOXM1 is a critical mediator of its pathogenesis. Here, FOXM1 is linked to prostate cancer.